Evidence map›Paper›PMID 30418175›Full record

ArticleThe Journal of clinical investigation2018

Insulin receptor signaling regulates renal collecting duct and intercalated cell antibacterial defenses.

Matthew J Murtha, Tad Eichler, Kristin Bender, Jackie Metheny, Birong Li, Andrew L Schwaderer, Claudia Mosquera, Cindy James, Laura Schwartz, Brian Becknell and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. LDL receptor-mediated endocytosis ofProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Insulin receptor orchestrates kidney antibacterial defenses.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  15. Life science alliance · 2024
    Article
  16. Article
  17. Intercalated cell function, kidney innate immunity, and urinary tract infections.Pflugers Archiv : European journal of physiology · 2024
    Review
  18. Article
  19. Article
  20. Uropathogen and host responses in pyelonephritis.Nature reviews. Nephrology · 2023
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Matthew J MurthaCenter for Clinical and Translational Research, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.
Tad EichlerCenter for Clinical and Translational Research, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.
Kristin BenderCenter for Clinical and Translational Research, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.
Jackie MethenyCenter for Clinical and Translational Research, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.
Birong LiCenter for Clinical and Translational Research, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.
Andrew L SchwadererCenter for Clinical and Translational Research, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.
Claudia MosqueraCenter for Clinical and Translational Research, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.
Cindy JamesMass Spectrometry and Proteomics Facility, The Ohio State University, Columbus, Ohio, USA.
Laura SchwartzCenter for Clinical and Translational Research, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.
Brian BecknellCenter for Clinical and Translational Research, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.
John David SpencerCenter for Clinical and Translational Research, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.
Nationwide Children's Hospital · USThe Ohio State University · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
Coordinating and Bioinformatics Unit for the MMPC/DiaCompU24DK076169 · NIDDK · AUGUSTA UNIVERSITY · PI MCINDOE, RICHARD A. · 2006 to 2018
$42.4M
Linking Insulin Signaling to Antimicrobial Peptide Production and the Kidney's Antibacterial DefensesR01DK114035 · NIDDK · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI SPENCER, JOHN DAVID · 2018 to 2021
$1.4M
Role of urothelium in epithelial integrity and innate defense of the kidneyK08DK102594 · NIDDK · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI BECKNELL, BRIAN · 2015 to 2019
$745k
NCI NIH HHS P30 CA016058NIDDK NIH HHS K08 DK102594NIDDK NIH HHS R01 DK114035NIDDK NIH HHS U24 DK076169
6 · The paper itself

Abstract

People with diabetes mellitus have increased infection risk. With diabetes, urinary tract infection (UTI) is more common and has worse outcomes. Here, we investigate how diabetes and insulin resistance impact the kidney's innate defenses and urine sterility. We report that type 2 diabetic mice have increased UTI risk. Moreover, insulin-resistant prediabetic mice have increased UTI susceptibility, independent of hyperglycemia or glucosuria. To identify how insulin resistance affects renal antimicrobial defenses, we genetically deleted the insulin receptor in the kidney's collecting tubules and intercalated cells. Intercalated cells, located within collecting tubules, contribute to epithelial defenses by acidifying the urine and secreting antimicrobial peptides (AMPs) into the urinary stream. Collecting duct and intercalated cell-specific insulin receptor deletion did not impact urine acidification, suppressed downstream insulin-mediated targets and AMP expression, and increased UTI susceptibility. Specifically, insulin receptor-mediated signaling regulates AMPs, including lipocalin 2 and ribonuclease 4, via phosphatidylinositol-3-kinase signaling. These data suggest that insulin signaling plays a critical role in renal antibacterial defenses.

Indexed as

Signal Transductionalpha-DefensinsAnimalsBacterial InfectionsDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2Kidney Tubules, CollectingMiceMice, Mutant StrainsReceptor, InsulinUrinary Tract Infectionsalpha-DefensinsReceptor, InsulinImmunologyInsulin signalingNephrologyUTI/pyelonephritis

Identifiers

PMID30418175
PMCPMC6264632
OpenAlexW2899958048

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.